NanoViricides Inc NNVC:NYSE American

RT Quote | NYSE American | USD
Last | 02/26/21 EST
4.18quote price arrow up+0.05 (+1.21%)
Volume
131,383
52 week range
2.85 - 12.75

...

Loading . . .

KEY STATS

  • Open4.00
  • Day High4.20
  • Day Low3.86
  • Prev Close4.18
  • 52 Week High12.75
  • 52 Week High Date03/06/20
  • 52 Week Low2.85
  • 52 Week Low Date12/31/20
  • Market Cap44.64M
  • Shares Out10.68M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.80
  • 1 Year % Change-59.5

RATIOS/PROFITABILITY

  • EPS (TTM)-1.91
  • P/E (TTM)-2.19
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-8.234M
  • ROE (MRQ)-82.32%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/31/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest NanoViricides Inc News

There is no recent news for this security.

Latest NNVC News From Our Partners

QUOTE FINDER

Profile

MORE
NanoViricides, Inc. is a nano-biopharmaceutical research and development company. The Company is engaged the discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company provides nanoviricide technology, which enables direct attacks at multiple points on a virus particle. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously...
Anil Diwan Ph.D.
Chairman
Meeta Vyas
Chief Financial Officer
Address
1 Controls Dr
Shelton, CT
06484-6153
United States